Skip to content

Assembly Biosciences ASMB Other Non-Current Assets

Other Non-Current Assets at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$4.89M+272%
ALN
Alnylam PharmaceuticalsALNY
$63.55M-13.9%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$131K+285%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$24.04M+310%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$40.24M-30.1%
Absci Corporation logo
Absci CorporationABSI
$383K-39.3%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's other non-current assets?
Assembly Biosciences (ASMB) reported other non-current assets of $312K in Q1 2026.
How has Assembly Biosciences's other non-current assets changed year-over-year?
Assembly Biosciences's other non-current assets decreased by 0.0% year-over-year, from $312K to $312K.
What is the long-term trend for Assembly Biosciences's other non-current assets?
Over 5 years (2020 to 2025), Assembly Biosciences's other non-current assets has grown at a -45.3% compound annual growth rate (CAGR), from $6.39M to $312K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.